Patents Assigned to l'Université Nice Sophia Antipolis
  • Publication number: 20160298115
    Abstract: The present invention relates to compositions comprising an agent, like a polynucleotide, which induces or upregulates expression of UCP1 for use in treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject. The present invention also relates to a method of treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject comprising administrating a composition comprising a polynucleotide which induces or upregulates expression of UCP1.
    Type: Application
    Filed: March 22, 2016
    Publication date: October 13, 2016
    Applicants: Centre National de la Recherche Scientifique, l'Université Nice Sophia Antipolis
    Inventors: Marcel SCHEIDELER, Michael KARBIENER, Ez-Zoubir AMRI, Gérard AILHAUD, Christian DANI
  • Patent number: 9320756
    Abstract: The present invention relates to compositions comprising an agent, like a polynucleotide, which induces or upregulates expression of UCP1 for use in treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject. The present invention also relates to a method of treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject comprising administrating a composition comprising a polynucleotide which induces or upregulates expression of UCP1.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: April 26, 2016
    Assignees: Centre National de la Recherche Scientifique, l'Université Nice Sophia Antipolis
    Inventors: Marcel Scheideler, Michael Karbiener, Ez-Zoubir Amri, Gérard Ailhaud, Christian Dani